Molecular Templates Q3 EPS $(0.82) Beats $(1.39) Estimate, Sales $5.73M Beat $2.46M Estimate
Portfolio Pulse from Benzinga Newsdesk
Molecular Templates (NASDAQ:MTEM) reported Q3 earnings with an EPS of $(0.82), surpassing the $(1.39) estimate, marking a significant improvement from the $(6.60) per share loss in the same quarter last year. Sales reached $5.73M, exceeding the $2.46M estimate and showing a 35.19% increase from the previous year's sales of $4.24M.
November 13, 2023 | 9:46 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Molecular Templates reported a smaller-than-expected Q3 loss and higher sales, indicating a strong performance compared to last year and analyst estimates.
Beating both EPS and sales estimates usually leads to positive investor sentiment in the short term. The significant improvement from last year's losses and the substantial beat on sales estimates suggest a strong performance that could boost the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100